Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT06645535
Eligibility Criteria:
Inclusion Criteria:
1. Male or female, ≥18 years old;
2. With symptoms and signs of chronic heart failure, NYHA class II-IV;
3. LVEF≥50% according to the most recent echocardiography before screening, and no previous record of LVEF\<50%;
4. BNP \>35 pg/mL, or NT-proBNP \>125 pg/mL;
5. Comply with at least one of the following:
(1) LVMI ≥ 115g/m2 (men) 95g/m2 (women); (2) RWT \> 0.42; R (3) E/e '\>15; (4) septal e '\<7cm/s or lateral e' \<10cm/s or mean e '\<8cm/s; (5) TVR\>2.8m/s or PASP\>35mmHg.
Exclusion Criteria:
Patients with confirmed chronic or acute renal insufficiency (stage II-IV)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06645535
Study Brief:
Protocol Section:
NCT06645535